cGxP.wire https://validator.w3.org/feed/docs/rss2.html Hamlet BioPharma Advances Alpha1H into Phase 3 Trial Ionis Wins FDA Approval for TRYNGOLZA in Severe Hypertriglyceridemia Revolution Medicines Presents RAS(ON) Data at ESMO 2026 Draeger Receives FDA Clearance for Evita V800 Upgrade HUTCHMED Reports Strong Phase II Fanregratinib Data in ICC C Ray Therapeutics Secures Key Radiopharmaceutical License CalciMedica Secures $49M Financing to Advance PH Program Phanes Completes Phase 2 Enrollment for Spevatamig in PDAC Viking Therapeutics Launches Phase 1 Study of VK3019 for Weight Loss Sera Applauds Illinois Medicaid Coverage for PreTRM Blood Test Mabwell Receives China IND Clearance for 6MW5311 Cancer Therapy Abbisko Therapeutics and Lilly Expand Global R&D Partnership Cognivia and Mayo Clinic Partner to Improve Clinical Research Outcomes Allergan Aesthetics Wins Canada Approval for Boey Neurotoxin AbbVie Secures EU Approval for MAVIRET in Acute Hepatitis C Bridge to Life Showcases VitaSmart HOPE Data at ATC 2026 Ascletis Receives FDA IND Clearance for ASC35 Obesity Trial CereVasc Completes Pivotal STRIDE Trial Enrollment for eShunt Armata Secures $2.5M DoD Funding for AP-SA02 Mediar Starts Phase 1 Trial of MTX-439 in CKD Leal Therapeutics Doses First ALS Patient with LTX-002 Calico Wins FDA Breakthrough Status for Fosigotifator Delphi Diagnostics Validates EAI for Paclitaxel Benefit Hamlet BioPharma Expands Alpha1H Trial for Bladder Cancer CalciMedica Receives FDA Clearance to Continue Auxora KOURAGE Trial Quest Diagnostics Secures New York Approval for Haystack MRD Cancer Test Lys Therapeutics Advances LYS241 with €25M Funding Boost Knoa Pharma and GCAR Expand Glioblastoma Trial Efforts REPROCELL Files Japan Approval Application for Stemchymal® Genprex Strengthens REQORSA Cancer Gene Therapy Patent Pierre Fabre Secures EU Approval for BRAFTOVI in mCRC US WorldMeds Secures Full FDA Approval for TECELRA REGENXBIO Advances NAVSUNLI Toward Accelerated Approval AbbVie to Acquire Apogee in $10.9B Immunology Expansion Murj Expands Cardiac Care Platform Across Australia and NZ MoonLake Reports Strong Phase 3 Sonelokimab HS Results BioArctic, Lilly Partner on Next-Gen Brain Therapies Insilico Medicine and SK Bio Launch $2.5B CNS Alliance CeleCor Submits FDA NDA for Zalunfiban After Phase 3 Success Mighty Therapeutics Announces New Era in Mitochondrial Medicine CureGene Doses First Patient in Pivotal Evategrel Trial Antengene Signs Up to $1.9 Billion TCE Licensing Deal LOTTE Biologics Completes Songdo Plant 1 Construction INTCO Medical Unveils Advanced Healthcare Solutions at WHX 2026 5W AI Index Reveals New Pharma Visibility Leaders Online Merz Therapeutics and Teijin Secure Japan Approval for XEOMIN® CervoMed Secures $10 Million to Advance Brain Disease Pipeline MediThinQ Partners With Synovis to Advance Digital Microsurgery Channel Robotics Raises $4.6M for Endoscopic Robotics Braeburn Presents New BRIXADI Data at CPDD 2026